Small business program funding from the National Institute on Aging (NIA), part of the National Institutes of Health, helps advance research on care interventions, diagnostic tools, and therapies for Alzheimer’s disease and related dementias. A new paper, published August 10 in Alzheimer’s and Dementia: The Journal of the Alzheimer's Association, describes the impact and case studies of NIA’s $280 million investment in this research over the past 11 years through more than 600 grants to over 230 small businesses in 37 states.

“Small businesses play a crucial role in research to discover effective prevention and treatment strategies for Alzheimer’s and related dementias,” said NIA Director Richard J. Hodes, M.D. “This paper provides the historical context of NIA’s funding in this highly competitive area and features some of the successes made possible through our federal investment.”

NIA is the lead federal agency for Alzheimer’s and related dementias research. Alzheimer’s is a brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks. While it is the most common cause of dementia in older adults, it is not a normal part of aging.

Full article here

Download PDF copy of article here. 

If you are interested in this topic, check out the video of the session on Nursing Home Residents (April 2021) here. 

###